Metraipolis › archive › dc_bbb9070edbbf

Efficacy and safety of camrelizumab-based regimens in advanced squamous cell carcinoma patients: a prospective multicenter study — Europe PMC PMID:41800100

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41800100
DOI: 10.3389/fphar.2026.1767096
License (as archived): solo-consultazione
Archived: 2026-11-05T15:33:40.496Z
SHA-256 of the archived text: 96617602d39c4d1b9882775167b307d9ee474ff1cef8bf50cf6ade5103a883e2
Stable URL of this page: https://metraipolis.com/documento/dc_bbb9070edbbf

How to cite

Efficacy and safety of camrelizumab-based regimens in advanced squamous cell carcinoma patients: a prospective multicenter study — Europe PMC PMID:41800100 — Europe PMC (en), https://europepmc.org/article/MED/41800100 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbb9070edbbf (Metraipolis archive dc_bbb9070edbbf, sha256 96617602d39c4d1b9882775167b307d9ee474ff1cef8bf50cf6ade5103a883e2)

BibTeX

@misc{dcbbb9070edbbf,
  title = {Efficacy and safety of camrelizumab-based regimens in advanced squamous cell carcinoma patients: a prospective multicenter study — Europe PMC PMID:41800100},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41800100},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbb9070edbbf; sha256 96617602d39c4d1b9882775167b307d9ee474ff1cef8bf50cf6ade5103a883e2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41800100. Agents can read the archived copy with the MCP tool read_document.